ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
pld89
|
71 |
18K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
18K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CEO Presentation to 2023 Annual General Meeting
|
|
pld89
|
114 |
37K |
5 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
114
|
37K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
pld89
|
71 |
18K |
7 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
18K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
pld89
|
71 |
18K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
18K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
pld89
|
362 |
120K |
10 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
362
|
120K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
pld89
|
362 |
120K |
15 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
362
|
120K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
17 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
pld89
|
362 |
120K |
5 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
362
|
120K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
10 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
pld89
|
362 |
120K |
8 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
362
|
120K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
6 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
7 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
5 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
pld89
|
362 |
120K |
0 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
120K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
5 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
6 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
3 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
11 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
4 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
6 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
5 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Presentation
|
|
pld89
|
62 |
20K |
10 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
62
|
20K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
4 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
7 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
10 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
7 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
4 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
4 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
6 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
3 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
4 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
4 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
6 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
11 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
7 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
8 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
9 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
6 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
15 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
4 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
pld89
|
9.9K |
3.0M |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
9.9K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
7 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
3 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
pld89
|
574 |
197K |
10 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
574
|
197K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
pld89
|
17K |
6.7M |
13 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
pld89
|
574 |
197K |
2 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
574
|
197K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
pld89
|
574 |
197K |
7 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
574
|
197K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
pld89
|
574 |
197K |
8 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
574
|
197K
|
8
|
|